Skip to main content
63 results
Time to review: 1 hour
Type: Clinical resource or information Clinical Area: Asthma Status: Current

The playing cards on these slides and downloadable PDF playing cards are a way to trigger conversations with healthcare teams, and between pharmacists and patients regarding the use of/reliance on SABA inhalers. We invite you to use them to start a discussion!

Time to review: 30 minutes

Practical things you can do locally to help improve asthma outcomes.

Time to review: 30 minutes

Patients with respiratory symptoms and disease deserve a correct diagnosis and correct guideline driven care that is standardized, patient focused, delivered by a Health Care Professional (HCP) with suitable training and experience, at a site and within an appropriate timeframe to meet their needs. Sadly, patient groups such as the British Lung Foundation (BLF) and Asthma UK have recognised that too often this is not the case.

Time to review: 30 minutes

Inhaler devices may seem simple to use but they are often used incorrectly by patients and healthcare professionals alike.

Time to review: 30 minutes
Type: Clinical resource or information, PCRU Clinical Area: Asthma Status: Current

Fran Robinson talks to a patient who has had asthma all her life, feels that annual asthma reviews are a waste of time (except when they are conducted by PCRS members). In this article she explains why and Ren Lawlor, Senior Lecturer,  Advanced Nurse Practitioner,  Department of Adult Nursing and Paramedic Science, University of Greenwich reflects on this patient’s experiences.

Time to review: 15 minutes
Type: Health policy information Clinical Area: Asthma Status: Current

PCRS welcome this further update of the long established, comprehensive and highly respected BTS/SIGN guideline for asthma. We are pleased that today BTS/SIGN have announced that future UK-wide guidance for the diagnosis and management of chronic asthma will be jointly produced by BTS, SIGN and NICE, something PCRS has campaigned for (Keeley & Baxter 2018).

Time to review: 30 minutes

The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.